Elpiscience Biopharmaceuticals

📍 Shanghai, China🗓 Founded 2017👥 33 employees💰 Last funded Feb 2021
Biotechnology Research🌐 elpiscience.com
Website LinkedIn
Elpiscience is a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies for cancer patients worldwide. The company’s innovative approach is focused on removing immunosuppressive factors in the tumor microenvironment, by targeting the adenosine pathway and myeloid checkpoints. A pipeline of novel molecules has been developed using its proprietary platforms including a powerful Bispecific Macrophage Engager (BiME®) technology that connects and activates macrophages for solid tumor killing without causing cytokine storms.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in Elpiscience Biopharmaceuticals?
Elpiscience Biopharmaceuticals has 1 investors on record on gritt.io, 1 mid-stage.
When did Elpiscience Biopharmaceuticals last raise funding?
The most recent investment in Elpiscience Biopharmaceuticals recorded on gritt.io was in February 2021.
When was Elpiscience Biopharmaceuticals founded?
Elpiscience Biopharmaceuticals was founded in 2017.
What industry is Elpiscience Biopharmaceuticals in?
Elpiscience Biopharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Elpiscience Biopharmaceuticals based?
Elpiscience Biopharmaceuticals is headquartered in Shanghai, China.